Ligand validation:5OQ6

4K4: 2-[(2-methoxy-4-{[4-(4-methylpiperazin-1-yl)piperidin-1-yl]carbonyl}phenyl)amino]-5,11-dimethyl-5,11-dihydro-6H-pyrimido[4,5-b][1,4]benzodiazepin-6-one

4K4 is a Ligand Of Interest in 5OQ6 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5OQ6_4K4_A_301	49%	24%	0.162	0.908	1.53	1.6	3	14	0	0	100%	0.8988
5OOT_4K4_A_301	64%	24%	0.157	0.955	1.25	1.83	1	18	1	0	100%	1
5OQ5_4K4_A_301	60%	17%	0.13	0.915	1.78	1.82	10	12	0	0	100%	0.8943
5VBO_4K4_A_201	94%	23%	0.069	0.966	1.44	1.71	5	9	2	0	100%	1
7LEM_4K4_A_201	64%	9%	0.133	0.933	2.03	2.42	10	18	0	0	100%	1
7L9K_4K4_A_502	54%	10%	0.139	0.905	1.76	2.56	7	22	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.